GlassScriptPhysician profile
Mitesh Kothari
NPI 1306849799
$1,337.33
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $276 · 2020: $248 · 2021: $398 · 2022: $173 · 2023: $163 · 2024: $80.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $243.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $243.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $334.03 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $178.45 | 2019-2024 | |
| Astellas Pharma US INC | $138.11 | 2019-2024 | Veozah |
| Aspira Women'S Health INC | $94.86 | 2021 | |
| Mayne Pharma Commercial LLC | $82.96 | 2021-2024 | |
| Daiichi Sankyo INC. | $71.62 | 2019-2020 | |
| Therapeuticsmd, INC. | $70.81 | 2019-2022 | |
| Hologic Sales and Service, LLC | $59.56 | 2021-2022 | |
| Duchesnay USA Incorporated | $44.02 | 2019 | |
| Organon LLC | $43.68 | 2022-2023 | Nexplanon |
| Axonics, INC. | $43.11 | 2023 | Axonics |
| Innovation Technologies INC | $36.79 | 2021 | |
| Amag Pharmaceuticals, INC. | $29.54 | 2019 | |
| Olympus America INC. | $24.06 | 2019 | |
| Allergan, INC. | $19.14 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $16.16 | 2023 | Myfembree |
| Vertical Pharmaceuticals, LLC | $14.17 | 2019 | |
| Myovant Sciences INC. | $13.05 | 2022 | |
| Agile Therapeutics, INC. | $12.01 | 2022 | |
| Avion Pharmaceuticals | $11.20 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitesh Kothari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.